Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · IEX Real-Time Price · USD
7.47
-0.48 (-6.04%)
At close: Jul 2, 2024, 4:00 PM
8.04
+0.57 (7.63%)
After-hours: Jul 2, 2024, 7:49 PM EDT
Verrica Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for VRCA stock have an average target of 13.5, with a low estimate of 10 and a high estimate of 16. The average target predicts an increase of 80.72% from the current stock price of 7.47.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for VRCA stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +114.19% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +87.42% | May 14, 2024 |
| Needham | Needham | Strong Buy Maintains $8 → $16 | Strong Buy | Maintains | $8 → $16 | +114.19% | May 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +7.10% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +74.03% | Mar 1, 2024 |
Financial Forecast
Revenue This Year
25.37M
from 5.12M
Increased by 395.16%
Revenue Next Year
72.59M
from 25.37M
Increased by 186.12%
EPS This Year
-1.52
from -1.48
EPS Next Year
-1.02
from -1.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.4M | 99.8M | 210.0M | 367.5M | 451.5M |
| Avg | 25.4M | 72.6M | 146.8M | 268.2M | 347.4M |
| Low | 19.6M | 51.3M | 85.7M | 169.8M | 244.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 493.7% | 293.1% | 189.3% | 150.4% | 68.3% |
| Avg | 395.2% | 186.1% | 102.2% | 82.7% | 29.5% |
| Low | 282.5% | 102.0% | 18.0% | 15.7% | -9.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.06 | -0.60 | 0.43 | 4.41 | 4.41 |
| Avg | -1.52 | -1.02 | -0.31 | 2.09 | 2.63 |
| Low | -1.72 | -1.48 | -0.96 | 0.47 | 1.26 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 110.9% |
| Avg | - | - | - | - | 25.9% |
| Low | - | - | - | - | -39.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.